A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines
Conditions
- Glabellar Lines
- Glabellar Frown Lines
Interventions
- DRUG: Abobotulinumtoxin A (Espad Pharmed Darou Co.)
- DRUG: Abobotulinumtoxin A (Ipsen Co.)
Sponsor
Espad Pharmed